Your search returned 3 results.

Results
	1.	Effects of lorcaserin on pre-existing valvulopathy: A pooled analysis of phase 3 trials. MedStar authors: Weissman, Neil J PMID: 27888609 Year: 2017 Citation: Obesity. 25(1):39-44, 2017 Jan Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Fain R, Hall N, Shanahan WR, Smith SR, Weissman NJ DOI: https://dx.doi.org/10.1002/oby.21695 Add to cart (remove)
	2.	Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study. MedStar authors: Weissman, Neil J PMID: 22421927 Year: 2012 Citation: Obesity. 20(7):1426-36, 2012 Jul. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Randomized Controlled Trial Form of publication: Journal Article All authors: Anderson CM, Fidler MC, O'Neil PM, Raether B, Sanchez M, Shanahan WR, Smith SR, Weissman NJ, Zhang J DOI: http://dx.doi.org/10.1038/oby.2012.66 Add to cart (remove)
	3.	Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients. MedStar authors: Weissman, Neil J PMID: 30145941 Year: 2018 Citation: New England Journal of Medicine. 379(12):1107-1117, 2018 09 20. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Bohula EA, Bonaca MP, Brown C, Budaj A, CAMELLIA-TIMI 61 Steering Committee and Investigators, Dhadda S, Fanola CL, Francis B, Garcia-Castillo A, Gupta M, Im K, Inzucchi SE, Keech AC, Kuder J, Leiter LA, McGuire DK, Miao W, Patel T, Perdomo C, Qamar A, Ruff CT, Sabatine MS, Scirica BM, Smith SR, Weissman NJ, White HD, Wiviott SD DOI: https://dx.doi.org/10.1056/NEJMoa1808721 Add to cart (remove)

Powered by Koha